ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 92618 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 92618; 2) Community: the network communities that were significantly associated with the response to NSC 92618; 3) Molecule: the relationships between components within communities and NSC 92618; 4) MDR: the compounds that were significantly associated with the NSC 92618.

NSC Compound Enrichment Correlation
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0396077140933377 0.49902717
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0396077140933377 0.31340319
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0396077140933377 0.41442248
NSC 659390 Null 0.0396077140933377 0.43515285
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0396077140933377 0.50148872
NSC 664271 Null 0.0396077140933377 0.44712613
NSC 668264 Null 0.0396077140933377 0.45723534
NSC 671190 Null 0.0396077140933377 0.42828029
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.0396077140933377 -0.1752154
NSC 681279 5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) 0.0396077140933377 0.38284043
Total:118  Current:100    [First] [Prev] [Next] [Last]